Genetic overlap between idiopathic pulmonary fibrosis and COVID-19.
journal contribution
posted on 2022-07-05, 08:07 authored by Richard J Allen, Beatriz Guillen-Guio, Emma Croot, Luke M Kraven, Samuel Moss, Iain Stewart, R Gisli Jenkins, Louise V WainCoronavirus disease 2019 (COVID-19) is an infectious disease potentially leading to long lasting respiratory symptoms and has resulted in over 4 million deaths worldwide. Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease (ILD) characterised by an aberrant response to alveolar injury leading to progressive scarring of the lungs. Individuals with ILD are at a higher risk of death from COVID-19 [1]
Funding
Action for Pulmonary Fibrosis Mike Bray Research Fellowship
Wellcome Trust 221680/Z/20/Z
History
Citation
European Respiratory Society, 2022, https://doi.org/10.1183/13993003.03132-2021Author affiliation
Department of Health Sciences, University of LeicesterVersion
- AM (Accepted Manuscript)
Published in
The European respiratory journalPublisher
European Respiratory Society (ERS)issn
0903-1936eissn
1399-3003Acceptance date
2022-04-07Copyright date
2022Available date
2022-07-05Publisher DOI
Spatial coverage
EnglandLanguage
engUsage metrics
Categories
No categories selectedLicence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC